Maxim Group LLC Expands Healthcare Equity Research With the Appointment of a Senior Biotechnology Analyst

NEW YORK, NY--(Marketwired - Feb 24, 2014) - Maxim Group LLC, a leading full service investment banking, securities and wealth management firm announced the expansion of its Healthcare Equity Research platform with the appointment of Dr. Pamela Bassett as a Senior Vice President and Senior Biotechnology Analyst.

Dr. Bassett's career spans investment advisory, corporate strategy, business development and clinical practice. She was the founder of Strategy Signal, LLC, an independent equity research firm for institutional investors in association with IRC Securities. Dr. Bassett was previously Portfolio Manager of Protagoras Life Science Capital and prior to that she was a Managing Director and Senior Equity Analyst Life Sciences Research with Cantor Fitzgerald. Dr. Bassett was the founder BioTrend Corporation which provided strategic advisory services focused on emerging technologies and business strategies, mergers, acquisitions and alliances to major multi-national healthcare companies. Frequently quoted, her views have been read in Business Week, Barron's, The New York Times, The Boston Globe, The Street's Real Money and numerous journals and industry magazines. "As we continue to build the healthcare platform, we are confident Pamela's diversified background and experience will enable her to make significant contributions to the Maxim Group team," said Anthony V. Vendetti, Executive Managing Director and Head of Equity Research for Maxim Group.

Dr. Bassett received her M.B.A. from Wharton Graduate School, University of Pennsylvania, completed a Residency in Anesthesiology at Drexel University College of Medicine, and received her D.M.D. from Tufts University School of Dental Medicine and B.A. in Biology from Oakland University.

About Maxim Group LLC 

Maxim Group LLC is a full-service investment banking firm headquartered in New York. Maxim Group provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales and trading, equity research and prime brokerage services. The investment banking group focuses on middle market and emerging growth companies within the shipping, energy, health care, technology, retail, and business and financial services sectors. The institutional coverage of Maxim Group spans North and South America, Europe and Asia. Maxim Group LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Investor Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc. To learn more about Maxim Group, visit www.maximgrp.com.